Bioresorbable Polymers Market

Market Overview

Bioresorbable polymers, also known as degradable polymers are naturally compatible with the body and break down easily in water which makes them ideal for temporary implants that the body can absorb and process over time. Bioresorbable polymers are widely used in biomedical applications such as sutures, arterial stents, drug delivery devices, vascular grafts, temporary bone fixation devices and dissolvable stitches. They are often preferred over metallic orthopedic devices because their material composition and structure can be precisely controlled. Common bioresorbable polymers used in medical fields include polylactic acid (PLA), polyglycolic acid (PGA), and poly (lactic-co-glycolide) (PLGA) copolymers. Polylactic acid (PLA) also called polylactide, is the most frequently used bioresorbable polymer. It is mainly used in synthetic grafts, orthopedic treatments, sutures and drug delivery systems. Polyglycolic acid (PGA) or polyglycolide is another type of bioresorbable polymer which is commonly used in dissolvable sutures, orthopedic application and craniomaxillofacial surgery. Furthermore, bioresorbable polymers used in medical procedures lower the risk of post-surgery complications for patients without causing harm to their bodies. The key factors driving the bioresorbable market include the growing need for drug delivery systems, the increasing demand for biocompatible medical devices, the rising number of surgeries and favorable reimbursement policies.

Bioresorbable Polymers Market Size

Report	Details
Market Size Value	USD 22.15 Billion in 2023
Market Size Value	USD 60.58 Billion by 2032
CAGR	13.40%
Forecast Period	2024-2032
Base Year	2023
Historic Data	2020

Major vendors in the global bioresorbable polymers market are  Corbion N.V. , Evonik Industries AG, Foster Corporation, KLS Martin Group, DSM Biomedical, Ashland Global Holdings Inc., Zeus Industrial Products, Seqens Group, REVA Medical, LLC, Poly-Med Incorporated, Bezwada Biomedical, LLC, Nomisma Healthcare Pvt. Ltd., BMG Incorporated, Polysciences, Inc, Huizhou Foryou Medical Devices Co.Ltd., Musashino Chemical Laboratory, Ltd., and Henan Xinghan Biotechnology Co. Ltd. and Others.

Growing need for bioresorbable polymers in drug delivery applications

Polymers have significantly enhanced drug delivery technology by allowing for controlled release of medications in precise doses over long periods which includes cyclical dosing and delivery of both water-soluble and fat-soluble drugs. The field has advanced significantly from its initial use of basic materials. Today, the design of polymers is focused on achieving specific biological effects and customizing them for particular drugs. Bioresorbable polymers gives controlled release at targeted sites and stabilize unstable molecules like proteins and which can be engineered to bind with specific molecules for targeted drug delivery within the body. Polymers play an important role in polymer therapies and nanomedicines. Polymeric nanoparticles, typically solid and spherical structures made from organic or synthetic polymers which are particularly important for drug delivery. These nanoparticles are used to deliver a wide range of substances which includes small water-soluble and fat-soluble drugs, vaccines, peptides and large biological molecules.

Among the biodegradable polymers used to create effective polymeric nanoparticles are different grades of poly(lactide-co-glycolide) and poly(lactide) copolymers. The extensive capabilities of bioresorbable polymers for new drug delivery systems and nanomedicines are expected to drive market growth. As demand for advanced drug delivery systems in the medical field increases that will significantly boost the revenue of the bioresorbable polymers market. For instance, in September 2023, Zeus, a leading provider of advanced polymer solutions, introduced Absorv™ XSE oriented tubing which is a new addition to its range of bioabsorbable products. This tubing comes in various resins and sizes which makes it highly customizable and a viable alternative to permanent metallic implants in the body. This flexibility allows medical device manufacturers to explore new applications for bioresorbable stents beyond treating coronary artery disease that includes potential uses in cardiovascular and peripheral vascular systems and in the treatment of ear, nose and throat (ENT).

Market Dynamics

Drivers:

• Expanding pharmaceutical industry
• Advancements in medical technology and integration with advanced drug delivery system
• Growing need for bioresorbable polymers in drug delivery applications

Opportunities:

• Growing demand for bioresorbable polymers in tissue engineering
• Growth in orthopaedic applications
• Development of advance medical devices

Growing demand for bioresorbable polymers in tissue engineering

The growing demand for bioresorbable polymers in tissue engineering is driven by their unique benefits and expanding applications in regenerative medicine. Bioresorbable polymers are materials that naturally degrade and are absorbed by the body over time which eliminates the need for surgical removal after their function is complete. This property is particularly valuable in tissue engineering in which the goal is to repair or replace damaged tissues and organs. In tissue engineering, these polymers serve as scaffolds that provide temporary support for cell growth and tissue formation. As the tissue develops and integrates with the body's natural structures then the scaffold gradually breaks down and is absorbed. This process helps to minimize the risk of long-term complications and the need for additional surgeries. Bioresorbable polymers can be engineered to degrade at controlled rates which is essential for supporting tissue regeneration at the appropriate pace. Recent advancements in polymer chemistry and processing techniques have led to the development of new bioresorbable materials with enhanced properties which includes improved mechanical strength, biocompatibility and controlled degradation rates. These innovations have expanded the use of bioresorbable polymers in various applications such as bone and cartilage repair, vascular grafts and skin regeneration. The increasing focus on personalized medicine and the need for effective, minimally invasive treatments are further boosting the demand for bioresorbable polymers in tissue engineering. With the advancement in technology which holds the promise of more effective solutions for repairing and regenerating damaged tissues as a result in improving patient outcomes and advancing the field of regenerative medicine.

The market for bioresorbable polymers market is dominated by North America.

By analysing the bioresorbable polymers market globally across various country like North America, Europe, Asia-Pacific, and LAMEA in which North America holds the largest market share during the forecast period, driven by rising use of bioresorbable polymers in drug delivery and orthopedic applications in the region. The U.S. is a key center for healthcare research and development which is further boosting market growth in North America. Additionally, the rising demand for orthopedic and drug delivery applications supports the need for bioresorbable polymers in the area.

Asia Pacific region is expected to grow at the fastest rate during the forecast period. The growth is driven by increasing elderly population in countries such as China and Japan which is driving the demand for medical procedures, which is anticipated to boost market growth. High economic growth in emerging countries and rising disposable incomes make the Asia Pacific an attractive market for bioresorbable polymers. Furthermore, the other factors driving market growth in the Asia Pacific include the increasing number of hospitals, supportive reimbursement policies, favorable government initiatives, rising per capita income, substantial investments in healthcare, demand for advanced surgical products and the expansion of private hospitals into rural areas. Higher healthcare spending and the growing need for polymers in drug delivery and orthopedic applications are expected to boost product demand in the region.

The polylactic acid (PLA) segment is anticipated to hold the largest market share during the forecast period

The global market is categorized by type into polylactic acid (PLA), polyglycolic acid (PGA) and polycaprolactone (PCL) polylactic-co-glycolic (PLGA) in which polylactic acid (PLA) segment held the largest market share. PLA-based products have the benefit of naturally converting into lactic acid in the body at low concentrations that can be safely eliminated through the excretory system. Additionally, their degradable nature means they dissolve safely, removing the need for a second surgery to take out components. The use of bioresorbable polymers like PLA is expected to grow in lumbar interbody fusion procedures. Polylactic acid's stiffness, biocompatibility, high strength, and high modulus make it ideal for manufacturing fixation devices like screws, pins, washers and arrows used in orthopedic surgeries.

The polyglycolic acid (PGA) segment is anticipated with the highest growth rate during the forecast period. Polyglycolic acid has rapid degradation compared to other biopolymers has led to increased demand for its use in drug delivery applications. Polyglycolic acid is used to deliver various substances which includes proteins, chemotherapy drugs, vaccines, pain relievers, antibiotics, siRNA and anti-inflammatory medications. Typically, bioresorbable polymers are organized into forms such as microcapsules, microspheres, nanofibers and nanospheres to enable precise control over the delivery of their contents.

Segmentations analysis of bioresorbable polymers market: -

• By Type:
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
  • Polycaprolactone (PCL)
  • Polylactic-Co-Glycolic (PLGA)
• By Application:
  • Orthopaedic Device
  • Drug Delivery
  • Other
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific

• • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia & New Zealand
  • Rest of Asia Pacific

• • Middle East & Africa

• • Saudi Arabia
  • UAE
  • South Africa
  • Nigeria
  • Egypt
  • Israel
  • Turkey
  • Rest of MEA

 Recent Developments

• September 2022, Ashland Group revealed plans to expand its Viatel bioresorbable polymer manufacturing and R&D facility at the National Science Park in Mullingar, Ireland. This site, which is part of a network of innovative organizations which highlights Ashland's dedication to advancing long-acting injectables. The expansion project began in June 2022 and is expected to be completed by 2024.
• May 2022, UBQ Materials, an Israeli company collaborated with Polymertal, a specialist in polymer metallization. This collaboration was to develop a lightweight and sustainable material for complex assemblies with metallic features.
• February 2022, 3D Biotek launched its new 3D Insert™ PCL scaffolds designed for large-scale 3D cell expansion. This technology provides a more accurate simulation of an in vivo environment compared to traditional 2D cell cultures. In September 2020, DSM formed a partnership with PBC Biomed, a medical device design company based in Ireland. The initial aim of this collaboration is on creation of regenerative bone adhesives to make surgical procedures safer and more cost-effective.

  Answers to Following Key Questions:

• What will be the bioresorbable polymers market ’s trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers in the bioresorbable polymers market?
• What are the main forces behind worldwide bioresorbable polymers market? Which companies dominate bioresorbable polymers market?
• Which companies dominate bioresorbable polymers market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the global Insight Engines industry's suppliers' opportunities and dangers in bioresorbable polymers market?
• What is the Insight Engines industry's regional sales, income, and pricing analysis? In the bioresorbable polymers market, who are the distributors, traders, and resellers?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the bioresorbable polymers market?
• What are the main geographical areas for various industries that are anticipated to observe astounding expansion for bioresorbable polymers market?
• What are the dominant revenue-generating regions for bioresorbable polymers market, as well as regional growth trends?
• By the end of the forecast period, what will the market size and growth rate be?
• What are the main bioresorbable polymers market trends that are influencing the market's expansion?
• Which key product categories dominate bioresorbable polymers market? What is bioresorbable polymers market’s main applications?
• In the coming years, which bioresorbable polymers market technology will dominate the market?